Findings

What do systematic reviews say?

50 questions · 56 findings · 6 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 11 · 19.6%GRADE not reported 4 · 7.1%Very low 22 · 39.3%Low 14 · 25%Moderate 2 · 3.6%High 3 · 5.4%

Pharmacological interventions vs placebo

EPO Duo score(0 to 40) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Pharmacological interventions vs placebo

Cholestyramine 0 to 3 severity scale · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 15 participants
Low

Pharmacological interventions vs placebo

Smoking cessation · young people

It is very uncertain whether pharmacological interventions changes bupropion vs placebo Smoking cessation compared with placebo (very low certainty).

3 findings from 1 review

Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
RR 1.49 [0.55, 4.02]
1 study · 207 participants
Very low
Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
RR 1.05 [0.41, 2.69]
1 study · 211 participants
Very low
Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
RR 1.11 [0.48, 2.58]
2 studies · 385 participants
Very low

Pharmacological interventions vs placebo

Adverse events (control ‐ placebo) · young people

3 findings from 1 review

Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 207 participants
Very low
Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 211 participants
Very low
Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 385 participants
Very low

Pharmacological interventions vs placebo

Comparisons and outcomes · young people

The review found no eligible studies for this question.

1 finding from 1 review

Tobacco cessation interventions for young people 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antidepressants vs placebo

Depression: mean scores at end of treatment (Analysis 1.4) · people with stroke

1 finding from 1 review

Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 100 participants
Very low

Antidepressants vs placebo

Cognition at end of treatment · people with stroke

1 finding from 1 review

Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 48 participants
Very low

Antidepressants vs placebo

Activities of daily living · people with stroke

1 finding from 1 review

Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 116 participants
Very low

Antidepressants vs placebo

Disability: mean scores at end of treatment (Analysis 1.10) · people with stroke

1 finding from 1 review

Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 204 participants
GRADE not reported

Antidepressants vs placebo

Adverse events: death ‐ at end of treatment (Analysis 1.14) · people with stroke

It is very uncertain whether pharmacological interventions (antidepressants) changes adverse events: death ‐ at end of treatment Analysis 1.12 compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke 2020 · Cochrane Headline outcomes only
RR 1.25 [0.32, 4.91]
9 studies · 496 participants
Very low